Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Hyliion (NYSE American: HYLN) Secures $42M Contract, Boosting Tech Development

Hyliion Holdings Corp. has clinched a significant contract worth approximately $42 million from the Office of Naval Research, which marks a key advancement for the company. This deal allows Hyliion to design, develop, and deliver power generation units, solidifying its position in the clean …

Vinay Lochav | 24 July 2026

Knight-Swift Boosts Q2 Revenue 13% to $2.1B, Upbeat Outlook Ahead

Knight-Swift Transportation's second-quarter results highlighted renewed bullish sentiment in the trucking industry, with total revenue climbing 13% year-over-year to $2.1 billion, well above analyst expectations of $2.04 billion. The company's adjusted earnings totaled 63 cents per share, exceeding consensus projections by 12 cents and …

Vinay Lochav | 24 July 2026

AAR CORP (NYSE: AIR) Grants 161,500 Share Performance Incentive to CEO

AAR CORP (NYSE: AIR) has implemented a significant leadership initiative by granting CEO John M. Holmes a performance-based stock award of 161,500 shares, valued at roughly $15 million. This incentive aligns with the company’s strategy to bolster stockholder value and retain top executive talent …

Vinay Lochav | 24 July 2026

Archer-Daniels-Midland Co. (NYSE: ADM) Appoints Jeff Rowe as COO, $1.2M Salary

Archer-Daniels-Midland Co. has appointed Jeff Rowe as Executive Vice President and Chief Operating Officer, effective August 17, 2026. This key leadership change aims to bolster the company’s growth strategy and operational efficiency, positioning it favorably in the competitive agricultural sector.Key HighlightsJeff Rowe, formerly CEO …

Vinay Lochav | 24 July 2026

Badger Meter (NYSE: BMI) Q2 EPS Matches Consensus at $1.02, Eyes H2 Growth

Badger Meter, Inc. (BMI) reported earnings per share (EPS) of $1.02 for the second quarter of 2026, in line with analysts' expectations. This result illustrates the company's capacity to sustain profitability amid challenges, such as a 7% decrease in year-over-year sales during the quarter. …

Vinay Lochav | 24 July 2026

CFO Signals Job Cuts Amid Forecast Revision, Hit to European Markets

Volkswagen reported a profit shortfall for the most recent quarter and simultaneously lowered its sales target for 2026, a move that reverberated through the automotive supply chain and sent European equity markets into a brief sell‑off. The CFO outlined plans to shutter several production …

Vinay Lochav | 24 July 2026

C.H. Robinson (NASDAQ: CHRW) Faces $604M Damages From Trucking Verdict

C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) is grappling with a significant legal setback after a Dallas County jury awarded $604 million in damages connected to a recent trucking accident. This hefty figure poses a considerable financial risk, equating to a notable portion of the …

Vinay Lochav | 24 July 2026

Southern Copper Corporation Reports Insider Transaction by Director Luis Miguel Palomino Bonilla

Southern Copper Corporation has disclosed a transaction involving its director, Luis Miguel Palomino Bonilla. On July 24, 2026, Bonilla sold 100 shares of the company's common stock. This transaction is significant as it reflects insider activity that may be of interest to investors monitoring …

Shwetambri Chauhan | 24 July 2026

Citigroup Global Markets Holdings Inc. Announces New Contingent Income Auto-Callable Securities

Citigroup Global Markets Holdings Inc. has filed a pricing supplement for its new contingent income auto-callable securities, which are set to mature on July 27, 2027. This offering, which is based on the performance of the Invesco QQQ Trust, presents a unique investment opportunity …

Aakashdeep | 24 July 2026

Summit Therapeutics (NASDAQ: SMMT) Reports $690.7M in Cash Following Q2 Results

Summit Therapeutics Inc. (NASDAQ: SMMT) disclosed that its cash and investment holdings total $690.7 million at the close of the most recent quarter. This liquidity provides a solid foundation for the company’s ongoing oncology initiatives, including the development of its lead candidate, ivonescimab, which …

Vinay Lochav | 24 July 2026
Support

Hi! How can we help you today?

Loading…